CAS: 475468-09-8

(R,R)-Glycopyrrolate is an agent of anticholinergic, has the ability to reduce the frequency of drooling in vivo with developmental disabilities.

Glycopyrrolate is a drug that is used to treat drooling, chronic cough, and bowel disease. It is an anticholinergic drug that blocks the action of acetylcholine in the body by blocking receptors for this neurotransmitter. Glycopyrrolate has been shown to have a low risk of drug interactions with other drugs due to its low plasma protein binding. Glycopyrrolate also has a stable dose-response relationship and does not need to be titrated for efficacy. The effects of glycopyrrolate are primarily on the gastrointestinal tract, where it inhibits gastric motility and reduces acid secretion. This medication also decreases the tone of smooth muscle in the bronchi, which helps relieve chronic coughs. In addition, glycopyrrolate may decrease the release of histamine from mast cells by inhibiting calcium release from intracellular stores in these cells. Glycopyrrolate also decreases muscle contractions in the uterus, which can help reduce